Physician profile
Paul Shapiro
NPI 1790896421
$1,463.47
in general payments reported to CMS, 2019-2025
23 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $99.59 · 2021: $197 · 2022: $227 · 2023: $409 · 2024: $158 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $337.83 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $173.19 | 2019-2024 | Grafix Pl, Grafix |
| Abbott Laboratories | $132.04 | 2021-2025 | Proclaim, Prodigy |
| Orthofix Medical, INC. | $117.85 | 2019-2025 | Physio-Stim |
| Stryker Corporation | $107.67 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.24 | 2021-2025 | Jublia |
| Grt US Holding, INC. | $61.65 | 2020-2021 | |
| Horizon Therapeutics Plc | $60.12 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $48.23 | 2019 | |
| Averitas Pharma INC. | $44.37 | 2024 | Qutenza |
| Bioventus LLC | $33.98 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $28.99 | 2025 | |
| Depuy Synthes Sales INC. | $28.45 | 2020 | |
| Aap Implants INC | $26.32 | 2022 | |
| Integra Lifesciences Corporation | $25.32 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $23.92 | 2020 | |
| Organogenesis INC. | $23.49 | 2023 | Puraply |
| Biom'Up France Sas | $22.17 | 2021 | |
| Globus Medical, INC. | $15.31 | 2025 | Senza |
| Zyla Life Sciences, INC. | $14.45 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.11 | 2023 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $12.72 | 2023 | Seglentis |
| Linvatec Corporation | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.